Research from the Federal University of Rio de Janeiro (UFRJ) and the National Institute of Science and Technology for Structural Biology and Bioimaging (INBEB) in Brazil has uncovered a critical ...

Alterations of the p53 gene, including point mutations and allelic loss, have been linked to a wide variety of human cancers (Hollstein et al., 1991), suggesting that the loss of wild type (wt) p53 ...

Figure 8: Regulation of ALDH3A1 and NECTIN4 by p53. Researchers Jessica J. Miciak, Lucy Petrova, Rhythm Sajwan, Aditya Pandya, Mikayla Deckard, Andrew J. Munoz, and Fred Bunz from the Sidney Kimmel ...

Outcomes of Radium-223 and Stereotactic Ablative Radiotherapy Versus Stereotactic Ablative Radiotherapy for Oligometastatic Prostate Cancers: The RAVENS Phase II Randomized Trial We analyzed a cohort ...

Serum was collected from 104 women (median age, 59 years; range, 34 to 89 years) at the time of their initial definitive surgery for ovarian cancer. Serum was analyzed by enzyme-linked immunosorbent ...

New research shows rapamycin’s powers go beyond slowing cell growth. It appears to shield DNA itself from damage. Since DNA breaks are a major driver of immune system decline, this discovery links ...

A ‘noisy’ chromatin structure allows cells to take on different identities, helping the immune system but possibly leading to ...

In the ovarian cancer cohort, the median time to response was 1.3 months and median duration of response was 7.6 months. Post the August 4, 2025 data cutoff date, the patients with uPRs remain on ...

In an otherwise treatment-refractory population, the combination shows favorable overall response rates in patients with ...

The world of protein engineering just took a giant leap forward. A team in China has developed a method that makes designing better proteins faster, cheaper, and easier.

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 / EINPresswire.com / -- What Is The Cellular Tumor Antigen p53 Market Size And Growth?